2013 Dodge Challenger R/T
5.7 L • V8 • 372 hp • RWD • MT
2C3CDYBT5DH684377
Sales history: 4
• $1,650Highlights
Condition
Run and drive
Seller
Financing • Southland FCU
Key included
Yes
Docs
Good
History
4 records
Drive
5.7 L • V8 • 372 hp • RWD • MT
Odometer
69,369 mi ≈ 111,638 km
Primary damage
Front end
Docs
TX • Cert Title
Auction
VIN
2C3CDYBT5DH684377
Lot number
68120395
Copart
Sale status
Sold
Seller type
Financing
Seller
Southland FCU
Location
Lufkin, TX
Description
Fuel type
Gasoline
Body color
Blue
Body type
Coupe
Generation
LC
Trim
R/T
All sales final. Always run reports before bid
Sharing our own experience
Over the years, we’ve learned all the ins and outs of car importing — so you don’t have to.
How it works
A full step-by-step guide that walks you through the entire process — from signing up to receiving your car at your doorstep. Clear & beginner-friendly.
Purchase process
Knowledge base
A structured library of content covering every major topic in car importing — including terms, rules, key concepts, and important real-world nuances.
Import encyclopedia
Watch & learn
Short, practical videos packed with tips from real experience. No fluff, no theory — just what actually helps when importing a car from the US to Poland.
Watch guides
Popular Dodge models
2013 Dodge Challenger R/T • 5.7 L • V8 • 372 hp • RWD • Manual • Copart Lot: 68120395 • VIN: 2C3CDYBT5DH684377
Find out more about this 2013 Dodge Challenger R/T, available at the Copart salvage car auction as lot #68120395 in Lufkin, TX. This car has Front end main damage. It is listed with Run and drive start condition code. Odometer shows 69,369 mi. This Blue Dodge Challenger Coupe is equipped with Gasoline 5.7 L engine, RWD drivetrain, Manual transmission. Check the vehicle history report for 2C3CDYBT5DH684377 to access detailed information on accidents, ownership, and title status. Review pricing trends and uncover hidden issues before placing your bid.
We use cookies to improve your experience and analyze site usage, as outlined in our Privacy policy. By closing this message or continuing to browse, you consent to their use.
